Home > BIO Analysis

Is Bio-Rad Laboratories, Inc. (BIO) Undervalued?

Based on the current stock price of $303.88 and a P/E ratio of 29.94,Bio-Rad Laboratories, Inc. has a PEG ratio of .

The Short Answer:

Most analysts consider a PEG ratio below 1.0 to be undervalued. With a ratio of , BIO appears to be fairly valued relative to its growth rate of -3.46%.

Valuation Status
Undervalued

Based on a PEG ratio of 0.00.

01.02.0+
P/E Ratio
29.94
Growth Rate
-3.46%
Stock Price
$303.88
Market Cap
8197113344

Compare BIO vs Competitors

Use the calculator below to see how BIO stacks up against other stocks in the same industry.

Analyze Any Stock

Get instant P/E, PEG, and PEGY ratios with real-time data

💡 Try popular stocks: AAPL, MSFT, GOOGL, TSLA, AMZN, NVDA, META

How we analyzed BIO

We calculated the PEG (Price/Earnings-to-Growth) ratio by taking the Price-to-Earnings Ratio of 29.94and dividing it by the annual growth rate of -3.46%.

PEG = 29.94 (P/E) ÷ -3.46 (Growth) =

Frequently Asked Questions about BIO

What is the current PEG Ratio for Bio-Rad Laboratories, Inc. (BIO)?+

The current PEG Ratio for Bio-Rad Laboratories, Inc. is N/A. A PEG ratio below 1.0 generally suggests the stock may be undervalued relative to its growth.

Is BIO stock undervalued right now?+

Based on the PEG ratio of N/A, Bio-Rad Laboratories, Inc. appears to be fairly valued. Investors typically look for a PEG ratio below 1.0 to find undervalued growth stocks.

What is the PEGY Ratio for BIO?+

The PEGY ratio for Bio-Rad Laboratories, Inc. is N/A. This metric accounts for dividend yield (0.00%), providing a more complete valuation picture.